Suppression of FOXM1 Activities and Breast Cancer Growth in Vitro and in Vivo by a New Class of Compounds

npj Breast Cancer - United Kingdom
doi 10.1038/s41523-019-0141-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Identification of a New Class of Natural Product MDM2 Inhibitor: In Vitro and in Vivo Anti-Breast Cancer Activities and Target Validation

Oncotarget
Oncology
2015English

PH Regulation by Breast Cancer Cells in Vitro and in Vivo.

1997English

In Vitro and in Vivo Anti-Trypanosoma Brucei Activities of Phenazinomycin and Related Compounds

Journal of Antibiotics
Drug DiscoveryPharmacology
2010English

NAHA, a Novel Hydroxamic Acid-Derivative, Inhibits Growth and Angiogenesis of Breast Cancer in Vitro and in Vivo

PLoS ONE
Multidisciplinary
2012English

In Vitro and in Vivo Antibacterial Activities of T-3262, a New Fluoroquinolone.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1988English

Suppression of FOXM1 Transcriptional Activities via a Single-Stranded DNA Aptamer Generated by SELEX

Scientific Reports
Multidisciplinary
2017English

Oncolytic Adenovirus Armed With IL-24 Inhibits the Growth of Breast Cancer in Vitro and in Vivo

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2012English

In Vitro and in Vivo Activities of DN-9550, a New Broad-Spectrum Cephalosporin.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1985English

In Vitro and in Vivo Antibacterial Activities of GV129606, a New Broad-Spectrum Trinem.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy